HIV Care Rounds | The Optimal Evaluation and Management of Osteoporosis in an HIV-infected Patient

Dr. Todd Brown
Assistant Professor of Medicine in the Division of Endocrinology and Metabolism at Johns Hopkins University


Dr. Brown is an Assistant Professor of Medicine in the Division of Endocrinology and Metabolism at Johns Hopkins University, the primary endocrine consultant to the Johns Hopkins HIV Clinic and a world-renowned lecturer and clinical investigator. His primary interest is in age-related metabolic, endocrine, and skeletal abnormalities in HIV-infected patients.


Presenter: Dr. Todd Brown
Location: Conference room 7, Providence Level 1, St. Paul’s Hospital
Date: Thursday, September 14, 2017
Time: 8:00-9:00 AM
Credit: This Group Learning program has been reviewed by the College of Family Physicians of Canada and British Columbia Chapter for up to 1 Mainpro+ credits.


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below